Some of our cancer centers are experiencing issues.  View More Important Notifications x
texas oncology more breakthroughs. more victories



Long-Term Adjuvant Endocrine Therapy Reduces Contralateral Breast Cancer Risk in Community Setting

Publication: Healio
Dr. Debra Patt, medical oncologist, hematologist and breast cancer specialist at Texas Oncology–Austin Central, contributed a perspective to Healio’s HemOnc Today that considered recent study results on adjuvant endocrine therapy and its impact on contralateral breast cancer risk in community settings. Dr. Patt’s article confirmed the magnitude of these results and highlighted useful knowledge surrounding adjuvant therapy.

Click here to read the full story from Healio.

Related Physicians